News – Kreussler Pharma and STD Pharm collaboration

PARIS, DECEMBER 14, 2023 | Kreussler Pharma – Chemische Fabrik Kreussler & Co. GmbH and S.T.D. Pharmaceutical Products Ltd. announced their collaboration on the worldwide production, marketing, and distribution of Fibrovein during Kreussler’s sponsored symposium at the 81st annual congress of the French Society of Phlebology.
“S.T.D. has been looking for a strategic partner for some time to gain synergies in the production and global marketing of Fibrovein. After Brexit, we decided to move the manufacture of Fibrovein to the EU and are now happy to partner with Kreussler, another family-owned business that we have long been acquainted with and that shares our values and vision to promote sclerotherapy,” said Bruce Gardiner, Director of S.T.D.
“As the owners of Aethoxysklerol and globally recognized experts in sclerotherapy, this collaboration is a unique opportunity for Kreussler to strengthen and further develop the position of sclerotherapy against alternative treatment options for varices. We are delighted to be now able to provide our customers with the world’s top 2 most important sclerosing agents. With our expert knowledge, infrastructure, and international network, Kreussler has the maximum ability to gain on production and marketing synergies for both, Aethoxysklerol and Fibrovein,” said Dr. Stephan Travers, Co-Owner and Director of Kreussler.
Sclerotherapy, being a highly efficacious, FDA-approved outpatient treatment for varicose veins, has a very good safety profile, while requiring no anaesthesia and being the most cost-effective method. To achieve the highest level of treatment skills, Kreussler has founded the Kreussler International School of Sclerotherapy (K.I.S.S.) offering a platform for training of aspiring sclerotherapists teaching the international standards of diagnostics and injection technique. The collaboration enables Kreussler to now integrate Fibrovein into the training program.

Contacts:
France
Dr. Serge Mako
Laboratoire Kreussler Pharma
[email protected]

Germany
Dr. Petra Gliem
Chemische Fabrik Kreussler & Co. GmbH
[email protected]

United Kingdom
Bruce Gardiner
S.T.D. Pharmaceutical Products Ltd
[email protected]